Edition:
United States

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

3.86USD
15 Dec 2017
Change (% chg)

$-0.21 (-5.16%)
Prev Close
$4.07
Open
$4.00
Day's High
$4.00
Day's Low
$3.82
Volume
89,380
Avg. Vol
57,101
52-wk High
$5.77
52-wk Low
$1.98

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.07 April 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Apr-17 1 22.60 22.60 22.60 --
Quarter Ending Jan-18 1 8.80 8.80 8.80 --
Year Ending Apr-17 1 62.29 62.29 62.29 --
Year Ending Apr-18 1 54.70 54.70 54.70 58.61
Earnings (per share)
Quarter Ending Apr-17 1 -0.07 -0.07 -0.07 --
Quarter Ending Jan-18 1 -0.12 -0.12 -0.12 --
Year Ending Apr-17 2 -0.77 -0.70 -0.84 --
Year Ending Apr-18 1 -0.44 -0.44 -0.44 -0.67

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Oct-17 13.54 12.78 0.76 5.59
Quarter Ending Jul-17 15.20 27.08 11.88 78.14
Quarter Ending Apr-17 22.60 17.90 4.70 20.78
Quarter Ending Jan-17 14.00 10.75 3.25 23.24
Quarter Ending Oct-16 17.98 23.37 5.39 30.01
Earnings (per share)
Quarter Ending Oct-17 -0.12 -0.28 0.16 -133.33
Quarter Ending Jul-17 -0.12 -0.06 0.06 -50.00
Quarter Ending Apr-17 -0.07 -0.16 0.09 -128.57
Quarter Ending Jan-17 -0.21 -0.28 0.07 -33.33
Quarter Ending Oct-16 -0.19 -0.14 0.05 -25.01

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Apr-17 22.60 -- -- -- --
Quarter Ending Jan-18 8.80 8.80 8.80 8.80 --
Year Ending Apr-17 62.29 -- -- -- --
Year Ending Apr-18 54.70 54.70 54.70 54.70 58.61
Earnings (per share)
Quarter Ending Apr-17 -0.07 -- -- -- --
Quarter Ending Jan-18 -0.12 -0.12 -0.12 -0.12 --
Year Ending Apr-17 -0.77 -- -- -- --
Year Ending Apr-18 -0.44 -0.44 -0.44 -0.44 -0.67

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Apr-17 -- -- -- --
Quarter Ending Jan-18 0 0 0 0
Year Ending Apr-17 -- -- -- --
Year Ending Apr-18 0 0 0 0
Earnings
Quarter Ending Apr-17 -- -- -- --
Quarter Ending Jan-18 0 0 0 0
Year Ending Apr-17 -- -- -- --
Year Ending Apr-18 0 0 0 0